Prevalence of Trichomonas vaginalis Among Married and Single Sexually Active Females in Oguta LGA, Imo State, Nigeria
DOI:
https://doi.org/10.63561/jber.v2i4.1035Keywords:
Prevalence, Infection, Trichomonas Vaginallis, Cervical Cancers, FemalesAbstract
Trichomonas vaginalis is one of the most common non-viral sexually transmitted infections globally. It is mostly attributed in females by a frothy-greenish yellow foul odour vagina discharge accompanied with vulva vaginal irritation, dyrusia and lower abdominal pains. Trichomonas is linked to increased mortality as well as a predisposing factor to HIV infections and cervical cancers. This study was conducted to determine the prevalence of Trichomonas vaginalis. infection among females in Ohaji Egbema, Ogut, Local Government Area. Imo State, Nigeria. Using vaginal swaps and urine samples, a total of 104 females between the ages of (14-43) years were examined. An overall prevalence of females within the age bracket of (24-28) years recorded the highest number of infections while no infections were recorded among the females between the age bracket of (14-18) years, the variation between singles and married was monitored and it was observed that married females had lower prevalence of this infection. There is a need for public health enlightening of adolescents, young female adults, including the elderly by religious organizations, relevant governmental and non-governmental agencies on sex education, public health implication of this infection and also the need to use protection or abstain from sex. Sexually active females should also be taught on how to practice monogamy.
References
Amadi, A. N. C., & Nwagbo, A. K. (2013). Trichomonas vaginalis infection among women in Ikwuano, Abia State, Nigeria. Journal of Applied Sciences and Environmental Management, 17(3), 389–393. DOI: https://doi.org/10.4314/jasem.v17i3.7
Andrea, S. B., & Chapin, K. C. (2011). Comparison of Aptima Trichomonas vaginalis assay and BD Affirm VPIII. Journal of Clinical Microbiology, 49(3), 866–869. https://doi.org/10.1128/JCM.02301-10 DOI: https://doi.org/10.1128/JCM.02367-10
Arbabi, M., Hejazi, S. H., & Mohraz, M. (2014). Comparison of diagnostic methods for Trichomonas vaginalis in symptomatic women: A study in Tehran, Iran. Journal of Clinical Microbiology, 52(9), 3252–3257. https://doi.org/10.1128/JCM.01956-14
Azambakhtiar, A., Nikmanesh, B., Rezaeian, M., Dashti, M. N., Safari, F., & Zarebavani, M. (2018). The prevalence of Trichomonas vaginalis in women referred to clinical centers in the south of Tehran, Iran (2015–2016). Iranian Journal of Parasitology, 13(1), 108–113. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6019587/
Bachmann, L. H., Hobbs, M. M., Seña, A. C., Sobel, J. D., Schwebke, J. R., Krieger, J. N., et al. (2011). Trichomonas vaginalis genital infections: Progress and challenges. Clinical Infectious Diseases, 53(Suppl. 3), S160–S172. https://doi.org/10.1093/cid/cir705 DOI: https://doi.org/10.1093/cid/cir705
Becton, Dickinson and Company. (2019). BD Viper™ XTR system. https://www.bd.com
Carter-Wicker, K., Utuama, O., & Omole, F. (2016). Can trichomoniasis cause pharyngitis? A case report. SAGE Open Medical Case Reports, 4, 2050313X16682132. https://doi.org/10.1177/2050313X16682132 DOI: https://doi.org/10.1177/2050313X16682132
Centers for Disease Control and Prevention. (2018, September 20). Expedited partner therapy. https://www.cdc.gov/std/ept/default.htm
Centers for Disease Control and Prevention. (2010). Sexually transmitted diseases treatment guidelines, 2010: Diseases characterized by vaginal discharge. https://www.cdc.gov/std/treatment/2010/vaginal-discharge.htm
Centers for Disease Control and Prevention. (2017, January 31). Trichomoniasis—CDC fact sheet. https://www.cdc.gov/std/trichomonas/stdfact-trichomoniasis.htm
Cepheid. (2019). Xpert® TV assay. https://www.cepheid.com
Cohen, M. S., Hobbs, M. M., Sena, A. C., & Swygard, H. (2004). Trichomoniasis: Clinical manifestations, diagnosis, and management. Sexually Transmitted Infections, 80(2), 90–95. https://doi.org/10.1136/sti.2003.005124 DOI: https://doi.org/10.1136/sti.2003.005124
Cotch, M. F., Pastorek, J. G., Nugent, R. P., Yerg, D. E., Martin, D. H., & Eschenbach, D. A. (1991).Demographic and behavioral predictors of Trichomonas vaginalis infection among pregnant women. Obstetrics & Gynecology, 78(6), 1087–1092. https://pubmed.ncbi.nlm.nih.gov/1945213/
Daugherty, M., Glynn, K., & Byler, T. (2019). Prevalence of Trichomonas vaginalis infection among U.S. males, 2013–2016. Clinical Infectious Diseases, 68(3), 460–465. https://doi.org/10.1093/cid/ciy490 DOI: https://doi.org/10.1093/cid/ciy499
Dopkins Broecker, J. E., & Huppert, J. S. (2011). Trichomoniasis in adolescents: Routine screening is advised for your patients at risk. Contemporary Pediatrics, 28, 28–46.
Fouts, A. C., & Kraus, S. J. (1980).Trichomonas vaginalis: Reevaluation of its clinical presentation and laboratory diagnosis. The Journal of Infectious Diseases, 141(2), 137–143. https://doi.org/10.1093/infdis/141.2.137 DOI: https://doi.org/10.1093/infdis/141.2.137
Galadanci, H. S., Abudu, O. O., Fagorala, I., Beyioku, A. F., & Anorlu, R. I. (2001). Prevalence of Trichomonas vaginalis in patients with vaginal discharge in Lagos, Nigeria. Nigerian Postgraduate Medical Journal, 8(4), 183–186 DOI: https://doi.org/10.4103/1117-1936.170928
Gaydos, C. A., Hsieh, Y. H., Barnes, M., Quinn, N., Agreda, P., Jett-Goheen, M., et al. (2011). Trichomonas vaginalis infection in women submitting self-obtained vaginal samples after internet recruitment. Sexually Transmitted Diseases, 38(9), 828–832. https://doi.org/10.1097/OLQ.0b013e31821f0f0f DOI: https://doi.org/10.1097/OLQ.0b013e3182228911
Gaydos, C. A., Schwebke, J., Dombrowski, J., Marrazzo, J., Coleman, J., Silver, B., et al. (2017). Clinical performance of the Solana® point-of-care Trichomonas assay. Expert Review of Molecular Diagnostics, 17(3), 303–306. https://doi.org/10.1080/14737159.2017.1282827 DOI: https://doi.org/10.1080/14737159.2017.1282823
Goyal, M., Hayes, K., McGowan, K. L., Fein, J. A., & Mollen, C. (2011). Prevalence of Trichomonas vaginalis infection in symptomatic adolescent females presenting to a pediatric emergency department. Academic Emergency Medicine, 18(7), 763–766. https://doi.org/10.1111/j.1553-2712.2011.01105.x DOI: https://doi.org/10.1111/j.1553-2712.2011.01111.x
Grama, D.F., Casarotti, L.D., Morato, M.G. (2013) 'prevalence of Trichomonas vaginalis and risk factors in women treated at public health unit in Brazil: a transversal study,' Transactions of the Royal Society of'Tropical Medicine and Hygiene;l07(9) :584-591. DOI: https://doi.org/10.1093/trstmh/trt063
Gregson, S., Mason, P.R., Gannett, G.P. (2001) ' A rural HIV epidemic in Zimbabwe ? Findings from a population -based survey," International Journal of STD and AIDS; 12 (3) 189-196. DOI: https://doi.org/10.1258/0956462011917009
Gumbo, F. Z., Duri, K., Kandawasvika, G. Q., Kurewa, N. E., Mapingure, M. P., Munjoma, M. W., et al. (2010). Risk factors of HIV vertical transmission in a cohort of women under a PMTCT program. Journal of Perinatology, 30(11), 717–723. https://doi.org/10.1038/jp.2010.44 DOI: https://doi.org/10.1038/jp.2010.31
Hobbs, M. M., Schwebke, J. R., & Seña, A. C. (2013).Trichomonas vaginalis: Genital infection, diagnosis, and management. Sexually Transmitted Diseases, 40(4), 326–331. https://doi.org/10.1097/OLQ.0b013e3182781947
Hollman, D., Coupey, S. M., Fox, A. S., & Herold, B. C. (2010). Screening for Trichomonas vaginalis in high-risk adolescent females. Journal of Pediatric and Adolescent Gynecology, 23(5), 312–316. https://doi.org/10.1016/j.jpag.2010.03.005 DOI: https://doi.org/10.1016/j.jpag.2010.03.004
Huppert, J. S., Hesse, E. A., Bernard, M. A., Xiao, Y., Huang, B., Gaydos, C. A., et al. (2011). Acceptability of self-testing for trichomoniasis increases with experience. Sexually Transmitted Infections, 87(6), 494–500. https://doi.org/10.1136/sextrans-2011-050014 DOI: https://doi.org/10.1136/sextrans-2011-050037
Kingston, M. A., Bansal, D., & Carlin, E. M. (2003). ‘Shelf life’ of Trichomonas vaginalis. International Journal of STD & AIDS, 14(1), 28–29. https://doi.org/10.1258/095646203321043228 DOI: https://doi.org/10.1258/095646203321043228
Kissinger, P. (2015) "Epidemiology and Treatment of Trichomoniasis," Current Infectious Disease Reports-17(6):425. DOI: https://doi.org/10.1007/s11908-015-0484-7
Kissinger, P., & Adamski, A. (2013). Trichomoniasis and HIV interactions: A review. Sexually Transmitted Infections, 89(6), 426–433. https://doi.org/10.1136/sextrans-2013-051005 DOI: https://doi.org/10.1136/sextrans-2012-051005
Madhivanan, P., Bartman, M. T., Pasutti, L., Krupp, K., Arun, A., Reingold, A. L., & Klausner, J. D. (2009). Prevalence of Trichomonas vaginalis infection among young reproductive‑age women in India: Implications for treatment and prevention. Sexual Health, 6(4), 339–344. https://doi.org/10.1071/SH09038. DOI: https://doi.org/10.1071/SH09038
Mahmoud, A., Sherif, N. A., Abdella, R., El‑Genedy, A. R., El Kateb, A. Y., & Askalani, A. N. H. (2015).Prevalence of Trichomonas vaginalis infection among Egyptian women using culture and latex agglutination: A cross‑sectional study. BMC Women’s Health, 15, Article 7. https://doi.org/10.1186/s12905‑015‑0169‑2 DOI: https://doi.org/10.1186/s12905-015-0169-2
Menezes, A. R., Lima, M. A., Ribeiro, A. C., & Santos, A. P. (2016).Trichomonas vaginalis in Brazilian women: Prevalence, risk factors, and diagnostic methods. Revista Brasileira de Ginecologia e Obstetrícia, 38(7), 328-335. https://doi.org/10.1055/s-0036-1581274 DOI: https://doi.org/10.1055/s-0036-1581274
Moodley, P., Connolly, Sturm, A.W. (2002) "Interrelationships among Human immunodeficiency virus type I infection, Bacterial vaginosis, Trichomoniasis, and the presence of Yeasts '•'Journal of infectious Diseases; 185: 69-73. DOI: https://doi.org/10.1086/338027
Nester, E. W., Anderson, D. G., Evans, C., Roberts, C. E. Jr., Pearsall, N., & Nester, M. T. (2001). Genitourinary infections: Protozoan sexually transmitted diseases. In Microbiology: A human perspective (pp. 657–658). McGraw-Hill College.
Nye, N.B., Schwebke, J.R., & Body, B.A. (2009) 'comparison of APTIMA Trichomonas vaginalis transcription- mediated amplification to wet mount microscopy, culture and polymerase chain reaction for diagnosis of trichomoniasis in. men and women.' American journal of Obstetrics and Gynecology; 200(2): 188. Workowski, K. A., & Bolan, G. A.; Centers for Disease Control and Prevention. (2015). DOI: https://doi.org/10.1016/j.ajog.2008.10.005
Quidel Corporation. (2019). Solana® Trichomonas assay. https://www.quidel.com
Rank, E. L., Sautter, R. L., Beavis, K. G., Harris, S., Jones, S., Drechsel, R., et al. (2011). Evaluation of the BD. Viper system with XTR technology. Journal of Laboratory Automation, 16(4), 271–275. https://doi.org/10.1016/j.jala.2011.01.003 DOI: https://doi.org/10.1016/j.jala.2011.03.001
Roth, M. T., Stern, M. E., & Swygard, H. (2011).Trichomonas vaginalis epidemiology and diagnostic accuracy: A review of current trends. Sexually Transmitted Diseases, 38(12), 1072–1079.https://doi.org/10.1097/OLQ.0b013e318235b49e
Schwebke, J. R., & Desmond, R. A. (2010). A randomized controlled trial of partner notification methods for prevention of trichomoniasis in women. Sexually Transmitted Diseases, 37(6), 392–396. https://doi.org/10.1097/OLQ.0b013e3181c3a8f4 DOI: https://doi.org/10.1097/OLQ.0b013e3181dd1691
Schwebke, J. R., Gaydos, C. A., Davis, T., Marrazzo, J., Furgerson, D., Taylor, S. N., et al. (2018). Clinical evaluation of the Cepheid Xpert TV assay. Journal of Clinical Microbiology, 56(2), e01237-17. https://doi.org/10.1128/JCM.01237-17 DOI: https://doi.org/10.1128/JCM.01091-17
Sexually transmitted diseases treatment guidelines, 2015. MMWR Recommendations and Reports, 64(RR-03), 1–137. https://stacks.cdc.gov/view/cdc/53167/cdc_53167_DS1.pdf (PMC5885289)
Soper, D. (2004). Trichomoniasis: Under control or undercontrolled? American Journal of Obstetrics and Gynecology, 190(1), 281–290. https://doi.org/10.1016/j.ajog.2003.08.023 DOI: https://doi.org/10.1016/j.ajog.2003.08.023
Sutton, M., Sternberg, M., Koumans, E. H., McQuillan, G., Berman, S., & Markowitz, L. (2007). The prevalence of Trichomonas vaginalis infection among reproductive‑age women in the United States, 2001–2004. Clinical Infectious Diseases, 45(10), 1319–1326. https://doi.org/10.1086/522532 DOI: https://doi.org/10.1086/522532
Thurman, A. R., & Doncel, G. F. (2011). Innate immunity and inflammatory response to Trichomonas vaginalis and bacterial vaginosis: Relationship to HIV acquisition. American Journal of Reproductive Immunology, 65(2), 89–98. https://doi.org/10.1111/j.1600-0897.2010.00876.x DOI: https://doi.org/10.1111/j.1600-0897.2010.00902.x
Trintis, J., Epie, N., Boss, R., & Riedel, S. (2010). Neonatal Trichomonas vaginalis infection: A case report and review of the literature. International Journal of STD & AIDS, 21(8), 606–607. https://doi.org/10.1258/ijsa.2009.009478 DOI: https://doi.org/10.1258/ijsa.2010.010174
World Health Organization. (2012). Global incidence and prevalence of selected curable sexually transmitted infections: 2008 estimates (WHO Library Cataloguing‑in‑Publication Data). WHO. https://apps.who.int/iris/handle/10665/75181
World Health Organization. (2019, June 6). Four curable sexually transmitted infections still affect millions worldwide. https://www.who.int/reproductivehealth/curable-stis/en/
Zalonis, C. A., Pillay, A., Secor, W., Humburg, B., & Aber, R. (2011). Rare case of trichomonal peritonitis. Emerging Infectious Diseases, 17(7), 1312–1313. https://doi.org/10.3201/eid1707.101217 DOI: https://doi.org/10.3201/eid1707.100892
